Antibacterial Synergists Market, By Synergist Type (Beta-Lactamase Inhibitors, Biofilm Disruptors, Efflux Pump Inhibitors and Others), By Formulation, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6315
|
Published Date
November 2026
|
Pages
280
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Antibacterial Synergists market size was valued at US$ 2,890.1 Million in 2025, expanding at a CAGR of 6.3% from 2026 to 2033.
Antibacterial synergists are chemical entities used in combination with antibacterial agents to increase the effectiveness of the active compound. They can help improve the efficacy of the antibiotic, make the antibiotic effective against resistant bacteria, and broaden the range of infections that the antibiotic is capable of treating. They are useful because they help the existing medications perform their intended function better. As antimicrobial resistance is on the rise, they have become very important to help ensure that the individual antibiotics are reliable. Hospitals need these types of medications because it will help them get more out of the medications that they are using. They are administered beyond hospital settings, such as in veterinary care, food safety, and medical devices. Hence, antibacterial synergists support improved treatment outcomes by enhancing antibiotic effectiveness and addressing the growing challenges of antimicrobial resistance.
Antibacterial Synergists Market- Market Dynamics
Rising Antimicrobial Resistance (AMR) growth to propel market demand
The rising prevalence of antimicrobial resistance (AMR) is expected to boost this market. Antibacterial synergists are drugs administered together with antibiotics to make them more effective against resistant bacteria by enhancing antimicrobial efficacy and minimizing bacterial resistance. In January 2026, research by NIH Gov, in Frontiers in Antibiotics, showed that antimicrobial resistance (AMR) is increasingly becoming a problem in India. 67% of antibiotics prescribed at a private pharmacy in an urban setting in India were prescribed without a prescription, whereas 44% of prescriptions made in the outpatient department were incorrectly prescribed for treatment of an acute respiratory infection. More than 60% of FDCs (fixed dose combinations) had no approval. The median cost of treatment for resistant infections was USD 199, whereas the median cost of treatment for susceptible infections was USD 109. It is clear that increasing problems of AMR are resulting in demand for antibacterial synergists to improve antibiotic effectiveness against bacterial infections.
Antibacterial Synergists Market- Segmentation Analysis:
The Global Antibacterial Synergists market is segmented on the basis of Synergist Type, Formulation, Application, End User, and Region.
Among the given synergist types, beta-lactamase inhibitors hold a prominent position in the market. This category includes agents like clavulanic acid, sulbactam, and tazobactam that prevent beta-lactam antibiotics from being destroyed by bacteria through enzymatic activity—the most prevalent mechanism of drug resistance. In February 2025, AbbVie Inc. received FDA approval for the new antibiotic combination therapy named EMBLAVEO™ (aztreonam and avibactam) for use in the U.S. The drug is used for the treatment of complicated intra-abdominal infections in patients infected with multi-drug-resistant gram-negative bacteria that produce various beta-lactamases. Thus, beta-lactamase inhibitors are therefore important for increasing the efficacy of antibiotics.
In the antibacterial synergists market, the gel formulation market helps in increasing the stability, slow release, and efficacy of antibacterial drugs, enabling their usage in many applications in the pharmaceutical and medical industry. In November 2025, Cipla Limited applied for an application for the research on the ophthalmic gel and the immunisation of the aminoglycoside antibiotic drug plazomicin for the treatment of ocular infection. Gel formulations are useful in providing improved delivery of the drugs while maintaining the stability of the drug. Hence, this leads to effective treatment of bacterial infections in various applications.
Antibacterial Synergists Market- Geographical Insights
The global Antibacterial Synergists market is significantly driven by North America due to the region having a strong advanced diagnostic infrastructure, an increased focus on combination drug development, strong antimicrobial stewardship strategies, and strict regulations relating to clinical evidence. In December 2025, for instance, according to a study published in NIH Gov, an analysis of advanced diagnostic infrastructure in 26 EU member states, 182 observations were made.
The study indicates that an average number of 363.63 CT scanners, 277.89 MRI scanners, 107.08 gamma cameras, and 36.98 PET scanners were observed. The maximum numbers were 2,446 CT scanners, 1,984 MRI scanners, 483 gamma cameras, and 233 PET scanners. Moreover, it was observed from the study that there is a positive correlation between national innovative capabilities and use of advanced technology, where MRI and PET scanners were the most preferred. This increased focus on advanced technology will help increase demand within the region for antibacterial synergists and combination-based treatment development.
Antibacterial Synergists Market- Competitive Landscape:
The global Antibacterial Synergists market is moderately diversified, where the players are mainly large pharmaceutical companies, specialists in antibiotics, and regional players. Some of the players in this market include Pfizer Inc., Merck & Co., Inc., Shionogi & Co., Ltd., AbbVie Inc., and GlaxoSmithKline plc. These companies have a wide range of antibiotics, research, and distribution networks around the world. In April 2026, Shionogi got a contract from BARDA’s Project BioShield, which was estimated at initially US$119 million and up to US$482 million in options, for the construction of the manufacture of U.S. drug products. This would allow the firm to create its antibiotic Fetroja, which is designed to treat drug-resistant and biothreat pathogens. This highlights how governments support the innovation in the field of antibacterials.
Recent Developments:
- In March 2025, GSK and BioVersys AG started a phase II clinical trial of alpebectir-ethionamide (AlpE). Alpibectir is used in this combined drug to enhance the antibacterial activities of ethionamide. The drug is being compared with the first-line tuberculosis treatments in order to ascertain its early bactericidal activities and safety for patients with pulmonary tuberculosis medicines. The trial aims at determining its early bactericidal activity and safety for patients with pulmonary tuberculosis.
- In February 2025, Pfizer Inc. and AbbVie Inc. brought EMBLAVEO (aztreonam-avibactam) nearer to the market by getting approval from the US FDA. The combination includes avibactam, which is an inhibitor of beta-lactamase, protecting aztreonam from the degradation by the bacterial enzymes. It would help in increasing the efficacy against multidrug-resistant Gramme-negative bacteria. Pfizer holds the marketing responsibility outside of the USA and Canada.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AbbVie Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Melinta Therapeutics, LLC
- Innoviva Specialty Therapeutics
- Allecra Therapeutics
- Basilea Pharmaceutica Ltd.
- Wockhardt Limited
- Meiji Seika Pharma Co., Ltd.
- Shionogi & Co., Ltd.
- Cipla Limited
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Aurobindo Pharma Limited
- Fresenius Kabi AG
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY SYNERGIST TYPE- MARKET ANALYSIS, 2020 - 2033
- Beta-Lactamase Inhibitors
- Clavulanic Acid
- Tazobactam
- Sulbactam
- Avibactam
- Vaborbactam
- Relebactam
- Durlobactam
- Enmetazobactam
- Others
- Biofilm Disruptors
- Enzymatic Agents
- Surfactants
- Chelating Agents
- Others
- Efflux Pump Inhibitors
- Synthetic Inhibitors
- Plant-Derived Inhibitors
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY FORMULATION- MARKET ANALYSIS, 2020 - 2033
- Gel
- Solid
- Powder
- Liquid
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Food Packaging
- Medical Devices
- Catheter Treatments
- Antibacterial Coatings
- Pharmaceuticals
- Oral
- Injectable
- Topical
- Personal Care Products
- Cosmetics
- Hygiene Products
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Personal Care Product Manufacturers
- Pharmaceutical Manufacturers
- Food and Beverage Manufacturers
- Research Institutes
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Antibacterial Synergists Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Antibacterial Synergists Key Market Trends
3.1. Antibacterial Synergists Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antibacterial Synergists Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antibacterial Synergists Market Opportunities
3.4. Antibacterial Synergists Market Future Trends
4. Antibacterial Synergists Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antibacterial Synergists Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Antibacterial Synergists Market Landscape
6.1. Antibacterial Synergists Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antibacterial Synergists Market – By Synergist Type
7.1. Overview
7.1.1. Segment Share Analysis, By Synergist Type, 2025 & 2033 (%)
7.1.2. Beta-Lactamase Inhibitors
7.1.2.1. Clavulanic Acid
7.1.2.2. Tazobactam
7.1.2.3. Sulbactam
7.1.2.4. Avibactam
7.1.2.5. Vaborbactam
7.1.2.6. Relebactam
7.1.2.7. Durlobactam
7.1.2.8. Enmetazobactam
7.1.2.9. Others
7.1.3. Biofilm Disruptors
7.1.3.1. Enzymatic Agents
7.1.3.2. Surfactants
7.1.3.3. Chelating Agents
7.1.3.4. Others
7.1.4. Efflux Pump Inhibitors
7.1.4.1. Synthetic Inhibitors
7.1.4.2. Plant-Derived Inhibitors
7.1.5. Others
8. Antibacterial Synergists Market – By Formulation
8.1. Overview
8.1.1. Segment Share Analysis, By Formulation, 2025 & 2033 (%)
8.1.2. Gel
8.1.3. Solid
8.1.4. Powder
8.1.5. Liquid
8.1.6. Others
9. Antibacterial Synergists Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Food Packaging
9.1.3. Medical Devices
9.1.3.1. Catheter Treatments
9.1.3.2. Antibacterial Coatings
9.1.4. Pharmaceuticals
9.1.4.1. Oral
9.1.4.2. Injectable
9.1.4.3. Topical
9.1.5. Personal Care Products
9.1.5.1. Cosmetics
9.1.5.2. Hygiene Products
9.1.6. Others
10. Antibacterial Synergists Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Personal Care Product Manufacturers
10.1.4. Pharmaceutical Manufacturers
10.1.5. Food and Beverage Manufacturers
10.1.6. Research Institutes
11. Antibacterial Synergists Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Antibacterial Synergists Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Antibacterial Synergists Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Denmark Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Antibacterial Synergists Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Antibacterial Synergists Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Antibacterial Synergists Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Synergist Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Antibacterial Synergists Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. AbbVie Inc.
12.2.2. Merck & Co., Inc.
12.2.3. Pfizer Inc.
12.2.4. GlaxoSmithKline plc
12.2.5. Melinta Therapeutics, LLC
12.2.6. Innoviva Specialty Therapeutics
12.2.7. Allecra Therapeutics
12.2.8. Basilea Pharmaceutica Ltd.
12.2.9. Wockhardt Limited
12.2.10. Meiji Seika Pharma Co., Ltd.
12.2.11. Shionogi & Co., Ltd.
12.2.12. Cipla Limited
12.2.13. Lupin Limited
12.2.14. Sun Pharmaceutical Industries Limited
12.2.15. Aurobindo Pharma Limited
12.2.16. Fresenius Kabi AG
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AbbVie Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Melinta Therapeutics, LLC
- Innoviva Specialty Therapeutics
- Allecra Therapeutics
- Basilea Pharmaceutica Ltd.
- Wockhardt Limited
- Meiji Seika Pharma Co., Ltd.
- Shionogi & Co., Ltd.
- Cipla Limited
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Aurobindo Pharma Limited
- Fresenius Kabi AG
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY SYNERGIST TYPE- MARKET ANALYSIS, 2020 - 2033
- Beta-Lactamase Inhibitors
- Clavulanic Acid
- Tazobactam
- Sulbactam
- Avibactam
- Vaborbactam
- Relebactam
- Durlobactam
- Enmetazobactam
- Others
- Biofilm Disruptors
- Enzymatic Agents
- Surfactants
- Chelating Agents
- Others
- Efflux Pump Inhibitors
- Synthetic Inhibitors
- Plant-Derived Inhibitors
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY FORMULATION- MARKET ANALYSIS, 2020 - 2033
- Gel
- Solid
- Powder
- Liquid
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Food Packaging
- Medical Devices
- Catheter Treatments
- Antibacterial Coatings
- Pharmaceuticals
- Oral
- Injectable
- Topical
- Personal Care Products
- Cosmetics
- Hygiene Products
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Personal Care Product Manufacturers
- Pharmaceutical Manufacturers
- Food and Beverage Manufacturers
- Research Institutes
- Others
GLOBAL ANTIBACTERIAL SYNERGISTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS